(Q37910652)

25 August 2017

1 reference

title

Significance of a positive urine group B streptococcal latex agglutination test in neonates (English)

1 reference

25 August 2017

Sánchez PJ

1

1 reference

25 August 2017

Siegel JD

series ordinal

2

1 reference

25 August 2017

Cushion NB

series ordinal

3

1 reference

25 August 2017

Threlkeld N

series ordinal

4

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 April 1990

1 reference

The Journal of Pediatrics

25 August 2017

published in

1 reference

25 August 2017

volume

116

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

601-606

1 reference

Rapid detection of neonatal group B streptococcal infections by latex agglutination

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981613-0

Commercial latex agglutination for detection of group B streptococcal antigen in body fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981613-0

Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum chemoprophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981613-0

Evaluation of a commercially available latex agglutination test for rapid diagnosis of group B streptococcal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981613-0

The neonatal blood count in health and disease.I. Reference values for neutrophilic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981613-0

Single-dose penicillin prophylaxis against neonatal group B streptococcal infections. A controlled trial in 18,738 newborn infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981613-0

ANTIGENIC RELATIONSHIPS BETWEEN GROUPS B AND G STREPTOCOCCI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981613-0

Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981613-0

10.1016/S0022-3476(05)81613-0

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference